Cadian Capital Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-284,422
Closed -$36.4M 56
2016
Q3
$36.4M Sell
284,422
-118,880
-29% -$15.2M 1.92% 20
2016
Q2
$50.3M Sell
403,302
-195,638
-33% -$22.5M 2.76% 11
2016
Q1
$50.1M Buy
598,940
+31,306
+6% +$2.58M 3.36% 9
2015
Q4
$56.2M Buy
567,634
+418,390
+280% +$44.9M 2.02% 18
2015
Q3
$18.3M Buy
149,244
+52,500
+54% +$7.13M 0.66% 44
2015
Q2
$14.8M Buy
+96,744
New +$16M 0.44% 48

Other funds holding ELGX

Cadian Capital Management's ELGX Position: Q4 2016 in Review

Cadian Capital Management sold out of Endologix Inc (ELGX) in Q4 2016, closing a stake of 284,422 shares — an estimated $36.4M sold.

Cadian Capital Management first reported a position in ELGX in Q2 2015 and held it in 6 quarters. The position peaked at $56.2M in Q4 2015. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • Cadian Capital Management reported no remaining Endologix Inc position as of Q4 2016 after selling out during the quarter.
  • Cadian Capital Management sold 284,422 Endologix Inc shares in Q4 2016, an estimated $36.4M.
  • Cadian Capital Management first reported a position in Endologix Inc in Q2 2015 and held it in 6 quarters.
  • Cadian Capital Management's Endologix Inc position peaked at $56.2M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on Cadian Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.